Curavit works with world-class principal investigators to identify endpoints and create protocols from “first principles” to design studies that are digitally native.

Curavit will manage your Institutional Review Board (IRB) process. We can work with your existing IRB or recommend an IRB for your study.

Curavit recruits participants from the 97% of potential patients who are traditionally excluded from clinical research, including ethnically and socio-economically underserved and underrepresented populations.

Curavit screens, consents, enrolls, and engages participants through Stratus, our proprietarty DCT platform.

Curavit coordinates all of the complex logistics - digital and physical - required to run a fully decentralized trial.

Curavit's central site supports 100% remote-based monitoring of patient activity to ensure patient safety, protocol adherence, and retention.

Curavit facilitates and manages participants' external labs and integrates the results into Stratus, our proprietary DCT platform.

Curavit's clinical study teams monitor trial data in real time to ensure patient safety, protocol adherence, and patient retention. This incorporates digital consent, telehealth, and remote data capture technologies.

Curavit's data management team creates the statistical plan and provides full data analysis for the final study report.

Curavit's regulatory affairs team oversees the process of getting your therapy or device through FDA review and approval and onto the market.